The Novo Nordisk Foundation is awarding DKK 14.4 million for 15 international initiatives that can mitigate the consequences of the COVID-19 pandemic in countries such as Sudan, Colombia and Myanmar.
The Novo Nordisk Foundation is awarding DKK 14.4 million for 15 international initiatives that can mitigate the consequences of the COVID-19 pandemic in countries such as Sudan, Colombia and Myanmar.
The Novo Nordisk Foundation has awarded up to DKK 250 million to Statens Serum Institut (SSI) in connection with the establishment of Testcenter Danmark, a national COVID-19 test centre.
The Novo Nordisk Foundation and the Carlsberg Foundation have donated DKK 17.5 million totally to establish a consortium comprising the Danish state, Carlsberg, Ørsted and Ree Holding, which will ensure emergency production of ethanol for disinfectants during the COVID-19 crisis.
Two recently-developed and highly sensitive antibody tests can make a major contribution to monitoring the transmission of COVID-19 during the pandemic and the development of antibodies at the individual level and in society as a whole. The new tests have been developed from scratch in close collaboration between Rigshospitalet, the University of Copenhagen and Novo Nordisk A/S, with support from the Carlsberg Foundation and the Novo Nordisk Foundation.
The Novo Nordisk Foundation has awarded a total of DKK 82.5 million for 45 projects that aim to mitigate the short-term health-related effects of the COVID-19 epidemic across the Danish Realm.
The Foundation is supporting four ambitious projects that, among other things, will focus on ensuring the supply of water and mitigating the risk of transmission.